pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma (Q90054171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

title

pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

Sharon R Pine

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

Antonina Mitrofanova

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

author name string

Sukanya Panja

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

publication date

6 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

published in

Communications Biology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

describes a project that uses

10 April 2020

ggplot2

object named as

ggplot2

2 references

10 June 2022

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pmc&rettype=xml&id=6731276

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

DESeq2

object named as

DESeq2 R package

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

DESeq2

0 references

Cytoscape

object named as

Cytoscape

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Epigenetics of lung cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Lung cancer: intragenic ERBB2 kinase mutations in tumours

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Mutation analysis of the PTEN/MMAC1 gene in lung cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Drug resistance in ovarian cancer — the role of p53

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

DNA methylation of DKK3 modulates docetaxel chemoresistance in human nonsmall cell lung cancer cell

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Methylation markers of early-stage non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Integrative (epi) Genomic Analysis to Predict Response to Androgen-Deprivation Therapy in Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

An integrative genomic and epigenomic approach for the study of transcriptional regulation

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Multiple network algorithm for epigenetic modules via the integration of genome-wide DNA methylation and gene expression data

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Comprehensive molecular profiling of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Personalized chemotherapy selection for breast cancer using gene expression profiles

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

A response prediction model for taxane, cisplatin, and 5-fluorouracil chemotherapy in hypopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Big Data Approaches for Modeling Response and Resistance to Cancer Drugs

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

The Generalization of `Student's' Problem when Several Different Population Variances are Involved

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Molecular signatures database (MSigDB) 3.0.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

The Reactome pathway Knowledgebase

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

KEGG: Kyoto Encyclopedia of Genes and Genomes

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Basic principles of ROC analysis

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Effect of site-specific DNA methylation and mutagenesis on recognition by methylated DNA-binding protein from human placenta

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Dynamic changes in the human methylome during differentiation

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Gene Expression Signature Predicts Recurrence in Lung Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Gene-expression profiles predict survival of patients with lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional TargetsCyr61andCTGF

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

https://api.crossref.org/works/10.1038/S42003-019-0572-6

1 reference

7 January 2021

Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Histological evolution from primary lung adenocarcinoma harboring EGFR mutation to high-grade neuroendocrine carcinoma.

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

A discussion on significance indices for contingency tables under small sample sizes

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Cytoscape: a software environment for integrated models of biomolecular interaction networks

1 reference

https://api.crossref.org/works/10.1038/S42003-019-0572-6

7 January 2021

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

1 reference

12 December 2020

MDR1 gene expression in primary and advanced breast cancer.

1 reference

12 December 2020

Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT.

1 reference

12 December 2020

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

12 December 2020

Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

1 reference

12 December 2020

Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond

1 reference

12 December 2020

Cancer Statistics, 2017.

1 reference

12 December 2020

10.1038/S42003-019-0572-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31508508 AND SRC:MED&resulttype=core&format=json

10 April 2020

PubMed publication ID

31508508

1 reference